Empirical evaluation of gene and environment interactions: Methods and potential

Journal of the National Cancer Institute

Volumn 103, Issue 16, 2011, Pages 1209-1210

  Prentice, Ross L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; EDITORIAL; ENVIRONMENTAL EXPOSURE; EVALUATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; FEMALE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052012688     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr279     Document Type: Editorial

References (11)

1. Campa D, Kaaks R, LeMarchand L, et al. Interaction between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst. 2011;103(16):1252-1263.
2. Travis RC, Reeves GK, Green J, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet. 2010;375(9732):2143-2151.
3. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-753.
4. Zhong H, Prentice RL. Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. Biostatistics. 2008;9(4): 621-634.
5. Zhong H, Prentice RL. Correcting 'winner's curse' in odds ratios from genomewide association findings for major complex human diseases. Genet Epidemiol. 2010;34(1):78-91.
6. Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008; 358(26):2796-2803. (Pubitemid 351930854)
7. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009; 360(6):573-587.
8. Stefanick ML, Anderson GL, Margolis KL, et al.; WHI Investigators. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006;295(14):1647- 1657.
9. LaCroix AZ, Chlebowski RT, Manson JE, et al.; WHI Investigators. Health outcomes after stopping conjugated equine estrogens among post-menopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305(13):1305-1314.
10. Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women's Study. Lancet. 2003;362(9382): 419-427. (Pubitemid 36999703)
11. Prentice RL, Huang Y, Hinds DA, et al. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(11):3079-3085.